Chlorhexidine Gluconate Wipes Market Research Report – Global Forecast till 2027

Chlorhexidine Gluconate (CHG) Wipes Market Information: by Product Type (CHG Bath Wipes, Others), by Concentration, Application, Distribution Channel, and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) — Global Forecast till 2027

ID: MRFR/HC/6095-CR | March 2019 | Region: Global | 110 pages

Chlorhexidine Gluconate (CHG) Wipes Market Overview:

The chlorhexidine gluconate (CHG) wipes market is expected to register a CAGR of 4.40% to reach USD 13948.89 thousand till 2023. CHG wipes are antiseptic wipes that contain Chlorhexidine Gluconate (CHG). These wipes are permeated with CHG which helps to kill bacteria and prevent wound infection.

The rising number of hospital-acquired infection (HAI) cases, an increasing number of surgical procedures & surgical site infections and growing geriatric population have led to the growth of the global CHG wipes market in the recent years. However, side-effects of CHG and product recalls are likely to restrain market growth over the forecast period.

Synopsis/Market Dynamics

The World Health Organization (WHO) stated that millions of patients are affected by healthcare-associated infections worldwide each year, leading to significant mortality and financial losses. According to a report published by the European Centre for Disease Prevention and Control in June 2017, approximately 30% of the patients in ICUs are affected by at least one episode of healthcare-associated infection. This huge population affected with healthcare-acquired infections is increasing the demand for CHG Wipes and contributing to boost the growth of CHG wipes market.

Segmentation

The global CHG wipes market, by product type, has been segmented into CHG bath wipes and CHG/alcohol-based wipes. The market, by CHG concentration, can be segmented into 2% and 0.5%. On the basis of application, the global CHG wipes market is segmented into surgical site infection, central line-associated bloodstream infection, catheter-associated urinary tract infections, and lens cleaners. The CHG wipes market on the basis of distribution channel, is segmented into hospitals & retail pharmacies and online platforms. The hospital and retail pharmacies segment accounted for a value of USD 6,407.63 in 2017.

Regional Analysis

The global CHG Wipes market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is expected to dominate the global CHG Wipes market. This is owing to the increasing prevalence of patients suffering from chronic illness with rising hospital admissions for surgical procedures. Also, high healthcare spending, well-developed technology, and increasing geriatric population are some factors that are expected to drive the market growth in the region.

Europe showed a considerable amount of growth in the market due to high healthcare spending. Asia-Pacific is estimated to be the fastest growing region in the global market. Enormous opportunities for the development of CHG wipes and the presence of a huge patient population are likely to be the key factors for the growth of the Asia-Pacific CHG wipes market during the forecast period. Australia held a share of 10.7% in the Asia-Pacific CHG Wipes market in 2017. On the other hand, the Middle East and Africa has the least share of the market due to the limited availability of funds and medical facilities.

Key Players

The prominent players in the global CHG wipes market are Becton, Dickinson and Company (US), 3M (US), Cardinal Health (US), GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK) and others.

Some of the key strategies followed by players operating in the chlorhexidine gluconate (CHG) wipes market were innovation, product development, acquisition, and expansion.

In May 2017, GAMA Healthcare Ltd acquired the Clinell division of its Australian distributor, AMCLA Pty Ltd, in Victoria. This investment demonstrates GAMA's continued commitment to infection prevention providing outstanding education, training, and clinical support to healthcare professionals across the world.

In October 2018, 3M announced the launch of SoluPrep Film-Forming Sterile Surgical Solution, a 2% chlorhexidine gluconate and 70% isopropyl alcohol surgical skin prep that are used to help clinicians in the fight against surgical site infections.

In July 2017, Cardinal Health acquired Medtronic’s patient care, deep vein thrombosis, and nutritional insufficiency business (patient recovery business).

Market Segmentation

Chlorhexidine gluconate (CHG) wipes market, by Product Type

CHG Bath Wipes

CHG/Alcohol-Based Wipes

Chlorhexidine gluconate (CHG) wipes market, by Concentration

Chlorhexidine gluconate (CHG) wipes market, by Application

Surgical Site Infection

Central Line-Associated Bloodstream Infection

Catheter-Associated Urinary Tract Infections

Lens Cleaners

Chlorhexidine gluconate (CHG) wipes market, by Distribution Channel

Hospital & Retail Pharmacies

Online Platforms

Chlorhexidine gluconate (CHG) wipes market, by Region

Americas

North America

Canada

Latin America

Europe

Western Europe

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

Middle East

Africa

Available Additional Customizations

Company Profiles of Other Key Players

Ecolab Inc.

Reynard Health Supplies

Schulke Australia Pty. Ltd

The Clorox Company

Investment Opportunities in the CHG Wipes Market

Intended Audience

Pharmaceutical Companies

Research Institutes

Hospitals

Report Scope:

Report Attribute/Metric	Details
Market Size	USD 13.95 Million
CAGR	4.40% (2018-2023)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Product Type, Concentration, Application, Distribution Channel, and Region
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Becton, Dickinson and Company (US), 3M (US), Cardinal Health (US), GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK) and others.
Key Market Opportunities	Development of CHG wipes and the presence of a huge patient population and Investment by industry players
Key Market Drivers	Increasing prevalence of surgical site infections.

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

What is the major driver for the Chlorhexidine Gluconate Wipes Market?

The market is majorly driven by the increasing prevalence of surgical site infections.

What is the key restraint on the Chlorhexidine Gluconate Wipes Market?

The side effects of CHG are the main restraint on the global market.

What is the leading regional market for chlorhexidine gluconate wipes?

The Americas hold the dominant share in the global market, due to the widespread adoption of CHG wipes in the healthcare sector in the region.

What are the key players in the Chlorhexidine Gluconate Wipes Market?

Leading players in the CHG wipes market include Becton Dickinson and Company, 3M, Cardinal Health, Carenow Medical, GAMA Healthcare Ltd., Lernapharm Inc., and PDI Limited, among others.

What is the growth rate of the Chlorhexidine Gluconate Wipes Market?

The CHG wipes market is expected to exhibit a solid 4.4% CAGR over the forecast period from 2020 to 2027.

1 Report Prologue

2 Introduction

2.1 Definition 15

2.2 Scope of the Study 15

2.3 List of Assumptions 16

2.4 Market Structure 16

3 Research Methodology

3.1 Research Process 18

3.2 Primary Research 19

3.3 Secondary Research 20

3.4 Market Size Estimation 20

3.5 Forecast Model 21

4 Market Dynamics

4.1 Introduction 23

4.2 Drivers 23

4.2.1 Rising hospital-acquired infections (HAI) 23

4.2.2 Increasing surgical procedures and surgical site infections 24

4.2.3 Rising geriatric population 24

4.3 Restraints 24

4.3.1 Side-effects of CHG 24

4.3.2 Product recalls 25

4.4 Opportunity 25

4.4.1 Entering Developing Economies 25

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 27

5.1.1 Bargaining Power of Suppliers 27

5.1.2 Bargaining Power of Buyers 28

5.1.3 Threat of New Entrants 28

5.1.4 Threat of Substitutes 28

5.1.5 Intensity of Rivalry 28

5.2 Value Chain Analysis 28

5.2.1 Research & Development 29

5.2.2 Manufacturing 29

5.2.3 Distribution 29

5.2.4 Marketing & Sales 29

5.2.5 Post-Sales Monitoring 29

6 Chlorhexidine Gluconate (CHG) Wipes Market, by Product Type

6.1 Introduction 31

6.2 CHG Bath Wipes 32

6.3 CHG/Alcohol-Based Wipes 33

7 Chlorhexidine Gluconate (CHG) Wipes Market, by Concentration

7.1 Introduction 35

7.2 2% 36

7.3 0.5% 36

8 Chlorhexidine Gluconate (CHG) Wipes Market, by Application

8.1 Introduction 38

8.2 Surgical Site Infection 40

8.3 Central Line-Associated Bloodstream Infection 40

8.4 Catheter-Associated Urinary Tract Infections 41

8.5 Lens Cleaners 41

9 Chlorhexidine Gluconate (CHG) Wipes Market, by Distribution Channel

9.1 Introduction 43

9.2 Hospital & Retail Pharmacies 44

9.3 Online Platforms 44

10 Global Chlorhexidine Gluconate (CHG) Wipes Market, by Region

10.1 Introduction 46

10.2 Americas 48

Chlorhexidine Gluconate (CHG) Wipes Market, by Product Type

Chlorhexidine Gluconate (CHG) Wipes Market, by Concentration